Predict contamination riskbefore it becomes a batch problem.

INSUS analyzes environmental, process, equipment and laboratory data to identify emerging contamination-risk patterns and give quality and production teams earlier opportunities to investigate. Quality teams keep the decision.

  • 01

    Contamination can develop before routine investigation identifies the cause.

  • 02

    Environmental and process signals often contain early warning patterns.

  • 03

    Flag the risk and investigate before it becomes a batch failure.

The problem

Contamination is investigatedafter the risk has already materialized.

Pharmaceutical manufacturing operates under strict quality requirements where contamination can compromise product quality, patient safety, compliance and production continuity. Sources can include personnel, facility conditions, raw materials, equipment, environment or transfer between products and batches. Traditional workflows often rely on scheduled monitoring, laboratory testing and investigations after an event, which can delay source identification and extend cleaning, rework and investigation cycles.

Pharmaceutical production environment with environmental and quality monitoring
01
02
03
  • 01Multiple contamination sources
  • 02Reactive investigation
  • 03Separated data streams

The shift

From contamination investigationto earlier risk visibility.

GMP practices, environmental monitoring and quality teams stay in charge. What changes is whether patterns associated with contamination risk are visible earlier across environmental, process and laboratory data.

Today

Investigate after the event

  • Scheduled monitoring and laboratory testing provide information after measurements or incidents occur.
  • Quality teams manually trace potential sources across people, equipment, processes and environment.
  • Batch rejection, cleaning and investigation can follow when contamination is detected late.

With INSUS

Identify elevated risk for earlier review

  • Environmental, process, equipment and laboratory data are combined into one risk view.
  • Unusual patterns and elevated contamination likelihood can be flagged for investigation.
  • Quality and production teams get explained alerts and context for follow-up.

How it works

From production-line datato earlier contamination-risk decisions.

This fits OptiStudio as quality and process decision support beside existing environmental monitoring, MES and LIMS systems. Access is read-only. It does not replace GMP or make quality-release decisions.

  1. Connect

    Bring environmental and process data together

    Connect available particle counts, temperature, humidity, differential pressure, airflow, process-control data, equipment parameters, LIMS results, MES batch records and relevant maintenance or deviation history.

  2. Understand

    Learn the plant's contamination-risk patterns

    Analyze how environmental conditions, process behavior, equipment state and historical contamination or deviation events have related on this production line or area.

  3. Detect

    Flag unusual patterns and elevated risk

    Identify abnormal environmental, process or equipment patterns and estimate elevated contamination likelihood against the plant's own baseline for quality-team review.

  4. Advise

    Explain the risk and recommend investigation

    Surface likely contributing factors and provide context-aware investigation options for quality, production and maintenance teams. Qualified personnel decide every action.

  5. Verify

    Validate against outcomes and investigations

    Compare flagged risks with actual monitoring results, deviations and investigation outcomes so the model can be refined for the specific line, area and product mix.

Pharmaceutical quality team reviewing contamination-risk predictions and alerts

Getting started

Start with one production lineand the monitoring you already run.

For pharmaceutical manufacturers that already collect environmental, process and quality data. Delivered through OptiStudio as contamination-risk decision support. Expert Services can help with data assessment and validation. Advisory only. Complements GMP and contamination-control strategies; does not replace them.

  • What we need. Available environmental-monitoring data such as particle counts, temperature, humidity, differential pressure and airflow; process and equipment data; LIMS and quality results; MES batch records; and relevant contamination or deviation history.
  • What you see first. One production line or process area: a back-test of flagged risk patterns against historical deviations and monitoring results before any live alert enters the quality workflow.
  • Where the limits are. Does not automatically make quality decisions or change process controls. Prediction is risk assessment, not a guarantee that contamination will or will not occur. Performance depends on accessible monitoring and deviation history.
Explore OptiStudio

Questions pharmaceutical manufacturers ask us

Contamination is often investigated after it has already affected a process or batch. This use case flags unusual environmental and process patterns and elevated contamination likelihood for quality-team review.

Environmental-monitoring data such as particle counts, temperature, humidity, differential pressure and airflow, plus process, equipment, LIMS and MES records and relevant deviation history. No new sensors when that monitoring already exists.

No. It is an advisory layer that complements existing Good Manufacturing Practices and Contamination Control Strategies. Qualified personnel remain responsible for decisions and actions.

No. It identifies risks and provides investigation context. Quality and production teams decide every response under existing procedures.

It estimates elevated risk from historical incidents and current conditions. Treat that as risk assessment, not a guarantee that contamination will or will not occur.

Through OptiStudio as quality and process decision support. Expert Services can support data assessment, integration and validation with your quality team.

Usefulness depends on accessible monitoring and deviation history. Recommendations are line- and area-specific. The system does not replace laboratory confirmation or batch-release decisions.

Pharma · Contamination risk prediction

Don't wait for contamination to become a batch investigation.

Use your existing environmental, process and quality data to identify emerging contamination-risk patterns and give teams earlier insight to investigate before an event becomes a larger production problem.